This job posting is no longer active.
Job ID: 57022
Location: Eugene, OR
Work Type: Full Time
Shift: Day
Shift Length: 8 Hours
FTE: 1.00
Benefit Eligibility: Full-time benefits
Description
PeaceHealth is seeking a Patient Access Rep Lead for a Full Time, 1.00 FTE, Day position. Hourly compensation is $19.86 – $34.88; hiring rate dependent on qualifications, professional experience, and/or work location.
***Hiring Bonus may be available!***
JOB SUMMARY
Assists in coordinating some or all of the following activities: scheduling; insurance verification and pre-certification; billing concerns and co-pay collections. Acts as a clinical liaison with physician practices interacting with pre-visit services.
Responsible for coordinating the day-to-day functions for assigned area. Assists with ensuring that departmental goals are achieved, timelines met and service excellence provided in all aspects of work. Subject matter expert.
ESSENTIAL FUNCTIONS
QUALIFICATIONS
EDUCATION:
EXPERIENCE/TRAINING:
OTHER SKILLS:
COMMUNITY/LOCATION SPECIFIC NOTES
PHMG Communities Only:
PHMG Clinics – Eugene/Springfield:
PHMG PHYSICAL/COGNITIVE REQUIREMENTS
PeaceHealth is committed to the overall wellbeing of our caregivers: physical, emotional, financial, social, and spiritual. We offer caregivers a competitive and comprehensive total rewards package. Some of the many benefits included in this package are full medical/dental/vision coverage; 403b retirement plan employer base and matching contributions; paid time off; employer-paid life and disability insurance with additional buyup coverage options; tuition and continuing education reimbursement; wellness benefits, and expanded EAP and mental health program.
See how PeaceHealth is committed to Inclusivity, Respect for Diversity and Cultural Humility.
For full consideration of your skills and abilities, please attach a current resume with your application. EEO Affirmative Action Employer/Vets/Disabled in accordance with applicable local, state or federal laws.
Must be fully vaccinated for COVID-19 including 2 doses of a 2-dose series or 1 dose of a 1-dose series plus 14 days beyond the final dose prior to start date.